Analytical Data
-
基因名
DERF2
- Application
-
别名
DERF2；MD1；Lymphocyte antigen 86
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q00855
-
表达区间
18-146aa
-
氨基酸序列
DQVDVKDCANNEIKKVMVDGCHGSDPCIIHRGKPFTLEALFDANQNTKTAKIEIKASLDGLEIDVPGIDTNACHFMKCPLVKGQQYDIKYTWNVPKIAPKSENVVVTVKLIGDNGVLACAIATHGKIRD
-
分子量
16.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DERF2, a member of the epidermal growth factor receptor (EGFR) family, has emerged as a significant player in the regulation of cellular processes such as growth, differentiation, and survival. Research indicates that DERF2 is actively involved in various signaling pathways that contribute to cancer progression, making it a potential target for therapeutic interventions. Given its structural and functional similarities to other EGFR family members, studies focusing on the recombinant expression of DERF2 protein have gained traction. The generation of DERF2 recombinant protein allows for better understanding of its biological role and interactions within cellular environments. Such studies can elucidate the mechanisms through which DERF2 influences tumorigenesis and identify potential biomarkers for cancer diagnosis and prognosis. Moreover, the recombinant DERF2 protein can serve as a valuable tool in drug development and validation, providing insights into the design of targeted therapies aimed at mitigating DERF2-related pathologies. As research advances, the exploration of DERF2’s structure-function relationships and its role in specific diseases continues to reveal promising avenues for therapeutic applications, underscoring the importance of DERF2 as a focal point in cancer biology and pharmacology.
